RxDoctor Payments Data

Muneera Panjwani, APRN

Gerontology · Middlebury, CTNPI 1053714170

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 65.6% of it on its own, with 8 other manufacturers making up the rest.

$848in general payments, 2019–2025

Across 31 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$556
  • SPR Therapeutics, Inc$111
  • Bioventus LLC$40
  • Vertos Medical, Inc.$37
  • Johnson & Johnson$31
  • Biohaven Pharmaceutical Holding Company Ltd.$23
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$848 in reported general payments places this provider in the 70th percentile of 90 gerontology providers in Connecticut.

See all gerontology providers in Connecticut

Medicare billing

Part B allowed, 2024
$67,779
Medicare patients
117
Services billed
3,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen14$47,489
OxycontinOxycodone Hcl37$26,255
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen304$7,765
Oxycodone Hcl305$6,664
Xtampza ErOxycodone Myristate13$5,813
Fentanyl22$3,850
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen170$3,602
Gabapentin186$3,568
Pregabalin175$2,515
Lidocaine22$2,381
Cyclobenzaprine Hcl88$1,854
Tramadol Hcl187$1,424
Tizanidine Hcl131$1,226
Diclofenac Sodium ErDiclofenac Sodium33$1,192
Morphine Sulfate ErMorphine Sulfate48$1,026

Paid to pharmacies, not to this prescriber.

Other gerontology in Middlebury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →